Morse Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Morse Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,885	Closed	-$948K	–	143
2022 Q2	$948K	Sell	11,885 -1,115	-9%	-$106K	0.3%	83
2022 Q1	$1.37M	Sell	13,000 -19,370	-60%	-$1.89M	0.34%	78
2021 Q4	$3.49M	Sell	32,370 -6,680	-17%	-$729K	0.78%	37
2021 Q3	$4.28M	Buy	39,050 +6,750	+21%	+$701K	1.02%	26
2021 Q2	$3.02M	Buy	32,300 +14,900	+86%	+$1.37M	0.73%	36
2021 Q1	$1.6M	Buy	17,400 +11,435	+192%	+$965K	0.41%	62
2020 Q4	$436K	Buy	5,965 +2,865	+92%	+$213K	0.12%	110
2020 Q3	$241K	Buy	+3,100	New	+$213K	0.08%	120

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morse Asset Management's HZNP Position: Q3 2022 in Review

Morse Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 11,885 shares — an estimated $948K sold.

Morse Asset Management first reported a position in HZNP in Q3 2020 and held it in 8 quarters. The position peaked at $4.28M in Q3 2021. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

Morse Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Morse Asset Management sold 11,885 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $948K.
Morse Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 8 quarters.
Morse Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.28M in Q3 2021.
530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Morse Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.